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Hypertension is an important worldwide public health care challenge, 
owing to its high prevalence and because it is a modifiable risk factor for 
cardiovascular, cerebrovascular and renal disease.1-3 The total number 
of adults with hypertension worldwide in 2000 was estimated at 972 
million; it has been predicted to be likely to increase by approximately 
60% to a total of 1.56 billion by 2025.4 Hypertension is the leading risk 
factor for mortality and is ranked third as cause of disability-adjusted 
life years.5 In South Africa cardiovascular disease is the second 
leading cause of death after HIV/AIDS, with hypertension the 
predominant contributor to the morbidity and mortality associated 
with the disease.
People with hypertension are frequently unaware that they have the 
condition, and it is often only detected incidentally during screening. 
Hypertension is therefore referred to as a ‘silent epidemic’ which is 
universally underdiagnosed and /or inadequately treated, resulting 
in extensive target-organ damage and premature death. Li et al.6 
showed that only 26% of populations were aware of their hypertension, 
only 3.9% achieved BP control of ≤140/90 mmHg, and lack of 
knowledge about hypertension and the importance of BP control were 
associated with poor compliance with both non-pharmacological and 
pharmacological treatment.6
In persons older than 50 years, systolic blood pressure (SBP) >140 
mmHg is considered a greater cardiovascular risk factor than raised 
diastolic BP (DBP). The risk of cardiovascular disease beginning at 
115/75 mmHg doubles with each increment of 20/10 mmHg, and 
individuals who are normotensive at age 55 have a 90% lifetime risk 
for developing hypertension.7 The importance of adequate treatment 
cannot be over-emphasised, e.g. 17 completed randomised controlled 
trials of BP-lowering drug treatment in a total of 47 000 patients with 
hypertension recorded 1 360 strokes over a 5-year period.8,9 Overall 
a net reduction of 5 - 6 mmHg in DBP and 10 - 12 mmHg in SBP 
achieved a 38% reduction in stroke risk.8 The impact of hypertension 
on all-cause mortality in a rural Nigerian population assessed by 
Kautman et al.10 in 1996 found that the risk of death increased by 60% 
with each increase of 20 mmHg in diastolic pressure. The estimated 
population attributable risk (the reduction in total mortality that would 
have been observed if hypertension were not present) was 7%.
The prevalence and severity of hypertension and the response 
to treatment differ in different ethnic groups. A study in randomly 
selected practices across South Africa, after age and gender 
standardisation, found that the overall prevalence of hypertension 
was 55%, which included a prevalence of 59% in black African (95% 
confidence interval (CI) 57 - 61), 55% in Indian and coloured (95% 
CI 52 - 59 and 52 - 58, respectively) and 50% in white people. In this 
study, hypertension was defined as a BP ≥140/90 or having a history 
of hypertension.11
Hypertension seems to be a more aggressive disease in black patients. 
Black people are more likely to develop hypertension and, compared 
with hypertension in other ethnic groups, the disorder is more severe, 
more resistant to treatment and more likely to be fatal at an early age.12,13  
This has important implications for the choice of an antihypertensive 
agent. Many drugs are available for reducing BP, notably thiazide 
diuretics, angiotensin-converting enzyme inhibitors (ACEIs), 
angiotensin-receptor blockers (ARBs), beta-blockers (BBs), calcium 
channel blockers (CCBs), alpha-blockers and direct vasodilators. In a 
study of predominantly black hypertensive patients conducted more 
than a decade ago in a predominantly urban population, Seedat14 
found that black patients responded best to diuretics, vasodilators or 
CCBs; their response to BB and ACEIs was poor, unless these agents 
were combined with thiazide diuretics. Current treatment guidelines 
recommend either thiazide diuretics, CCBs or vasodilators in black 
patients,15 but it is unknown to what extent these guidelines are being 
followed.
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Background. Reliable information about the prevalence of 
hypertension, which is a major contributor to cardiovascular 
disease in general and to coronary heart disease in particular, in 
different geographical regions is essential for its prevention and 
optimal control. In the mining industry, which comprises mainly 
urbanised black African men, the prevalence, impact, treatment 
and control of hypertension remains unexplored. 
Methods. We conducted a retrospective, descriptive 1-year 
hypertension prevalence study in Gauteng Harmony Mine 
Operations in South Africa. Patient profiles and blood pressure 
(BP) measurements were retrieved from the company electronic 
data systems. Follow-up entries made at all the different health 
facilities that serve this population were examined. Continuous 
variables were summarised using means or medians with standard 
deviations. Categorical deviations, including ethnicity, were 
summarised using percentages and/or frequencies.
Results. Of the 4 297 subjects (100% of the mining population in 
the study period), 4 286 (99%) were black Africans; 90% were men; 
mean age was 44.62 years; and 39.5% (N=1 696) had hypertension, 
for which 42% (N=719) received pharmacological treatment, of 
which 31% (13% of the total hypertensive population) achieved an 
adequate BP control target of <140/90 mmHg. Pharmacological 
treatment included diuretics (38.5%), angiotensin-converting 
enzyme inhibitors (30.16%), calcium channel blockers (26%), 
beta-blockers (4.47%), angiotensin-receptor blockers (0.17%) and 
centrally acting agents (0.07%), usually taken in combination.
Conclusion. We confirmed that hypertension is an important 
health challenge for the mining industry in South Africa. Detection, 
treatment and adequate control of hypertension should receive high 
priority from the mining authorities.
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More recently, the Heart of Soweto Study found a prevalence of 
hypertension of 56% in an urban South African community.16 Most 
patients were black Africans (85%, N=1 359), and the study population 
comprised more women (59%) than men. Most patients reporting to the 
Baragwanath Hospital cardiac unit showed late clinical presentations 
with established heart disease of more than one cause. Overall, the four 
most common diagnoses were hypertension, heart failure, valvular 
disease and coronary disease. Patients with hypertension and heart 
failure were a decade older than those with valvular heart disease. The 
three common forms of heart failure included dilated cardiomyopathy 
(35%), heart failure secondary to hypertension (33%) and right heart 
failure (27%) associated with cor pulmonale.16
Information regarding the prevalence and absolute burden of 
hypertension in the mining industry is lacking. We aimed to assess 
the 12-month prevalence, treatment and control of hypertension in 
goldminers working at Gauteng Harmony Gold Operations. Mining 
in South Africa is predominantly undertaken by black people, although 
the numbers of miners from other ethnic groups are increasing. In 
this setting hypertension is believed to contribute to morbidity and 
mortality and is a major contributor to absenteeism and decreased 
productivity. The complications of hypertension are reduced when 
BP is well controlled. Establishing the burden of hypertension would 
enable mining authorities to assign sufficient priority and resources to 
its management and prevention.
Methods
A literature search of primary and secondary sources provided 
background information. We undertook a retrospective analysis of 
the comprehensive electronic database of Harmony Health Centre 
to establish the 12-month prevalence of hypertension in goldminers 
at Gauteng Harmony Gold Operations from 1 February 2009 to 31 
January 2010.
The study population included all goldminers who attended 
Harmony health centres, which provide free primary health care, 
occupational services and admissions to hospital for its category 3 - 8 
employees. Category 3 - 8 employees, as classified by the Chamber 
of Mines agreement, are non-officials, most of whom have attained 
7 years of schooling, although a minority, especially women, have 
completed 12 years of schooling. It is compulsory for all goldminers 
to visit the occupational health centre, where their BP is routinely 
measured. Comprehensive data were therefore obtained. Most of the 
miners share the same daily hostel menu and hospital menu when 
admitted.
All the files of patients who attended the occupational health 
centre during the designated period were retrieved and the data 
were analysed. The prevalence of hypertension was obtained from 
the occupational health centre, and it included all study patients. 
The study comprised a total of 4 297 patients between the ages of 18 
and 69 years. Data included all patients with abnormal BP readings 
who were therefore referred to the primary health care centre for 
management.
All employees’ BP was measured with an electronic BP device. 
Two readings were taken and their average was recorded. Smoking, 
exercising or drinking coffee/tea 30 minutes before the BP 
measurement was not permitted.
Hypertension was defined as an SBP of at least 140 mmHg or DBP 
of at least 90 mmHg, or current use of antihypertensive medication 
irrespective of the level of BP. Poorly controlled hypertension was 
defined as BP of ≥140/90 mmHg. Well-controlled hypertension was 
defined as BP of <140/90 mmHg on treatment.
We collected data electronically and manually. Electronic data were 
retrieved by an information technology specialist from the Harmony 
Health systems database and used to establish the prevalence of 
hypertension. Manual data were collected by the researcher from 
patient files and used to ascertain which antihypertensive drug 
classes were used in this population and to determine the percentage 
of well-controlled and poorly controlled patients by pharmacological 
drug class category.
For the prevalence of hypertension, the entire study population 
was used as the denominator. The Excel Microsoft Office 2007 
computer programme was used for data analysis; it generated tables, 
graphs, pie diagrams and representation characteristics or values, 
such as averages and percentages.
Permission to obtain the data was obtained from Harmony 
Health Services authorities and study ethics approval was obtained 
from the Ethics Committee of the University of Pretoria. Patient 
confidentiality was maintained throughout the research.
Results
A total of 4 297 mine workers attended Harmony health centres 
during the period February 2009 - January 2010; 99.7% were black 
Africans, 0.09% were coloured and 0.16% were white (Fig. 1); 3 866 
(90%) were male and 431 (10%) were female (Fig. 2). The majority 
(69.8%) of the miners were older than 40 years. On average, women 
(33.27 years) were younger than men (45.89 years). Overall, their 
education level was low.
Fig. 1. Ethnic groups expressed as a percentage of the study population.
Fig. 2. Gender of the study participants.
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Prevalence of hypertension
The overall prevalence of hypertension was 39.5% (N=1 696), with 
a higher prevalence among males (40.5%) compared with females 
(29.9%). The prevalence of hypertension increased with age, ranging 
from 15.97% in the 18 - 29-year-old age group to 83.02% in the 60 
-69-year-old age group (Fig. 3).
Antihypertensive medication and BP control
Only 42% (N=719) of patients diagnosed with hypertension 
received pharmacological treatment for this condition (Fig. 4). In 
the hypertensive group taking medication, 13.35% (N = 96) were 
on monotherapy, while 86.65% (N=623) were taking two or more 
antihypertensive agents. Only 31% (N=223) reached their target 
level of BP control on treatment; 18% of these received monotherapy 
and 82% combination antihypertensive drug therapies. Despite 
pharmacological treatment, 69% of patients were poorly controlled. 
Of these, 11% were on monotherapy and 89% were taking multiple 
antihypertensive agents.
Pharmacological drug class
When the number of drug classes used per individual was assessed, 
13% of patients were treated with 1 drug class, 39% with 2 drug 
classes, 42% with 3 drug classes and 6% with 4+ drug classes (Fig. 
5). Pharmacological interventions in descending order included 
diuretics (38.5%), ACEIs (30.16%), CCBs (26%), BBs (4.47%), ARBs 
(0.17%) and centrally acting agents (0.07%) (Fig. 6).
Discussion
The large study population comprised predominantly black middle-
aged men who were experienced goldminers of low education, and 
presumably fit, in an urban setting. This provided a unique study 
population that to our knowledge has not been studied previously.
The prevalence of hypertension in this population was 39.5% 
which is at the upper end of the range (15 - 59%) of previously 
reported studies in black patients that included men and women.16,17 
The worldwide overall prevalence of hypertension is 26.8%. The 
prevalence of hypertension in the South African Heart of Soweto 
Study was 56%,16 in which the majority of the participants were 
urbanised and female, and possibly not as physically fit as our 
study population. This may impact on the differences seen in the 
prevalence of hypertension.
Only 42% of hypertensive patients in our study received 
antihypertensive treatment. This underlines the point that although 
the screening methods and detection of hypertension were excellent, 
58% of patients received no pharmacological therapy for this 
potentially lethal condition.
Of greater concern is that only 31% (N=223) of hypertensive 
patients on therapy, representing 13% of the total hypertensive study 
population, achieved an optimal BP control of <140/90 mmHg. This 
is an improvement on the 3.9% quoted by Li et al.,6 but remains far 
short of the recommendation that 50% of people with hypertension 
should attain proper BP control on treatment. This poor figure 
possibly reflects inadequate monitoring tools, lack of knowledge 
about hypertension, poor adherence to therapy and low levels of 
education among the employees. It may also reflect a gap in effective 
health programmes in the company. More could be done to control 
hypertension and thereby limit its complications.
The high use of diuretics, ACEIs and CCBs and low use of 
BBs is reassuring, as this is in line with hypertension treatment 
guidelines found in the 7th Report of the Joint National Committee 
on Prevention, Detection, Evaluation and Treatment of High Blood 
Pressure (JNC-7) and international hypertension guidelines.15 
Yet the most recent National Institute for Health and Clinical 
Excellence (NICE) guidelines advise against the use of ACEIs in black 
Fig. 3. Prevalence of hypertension per age group, and age of study partici-
pants expressed as a percentage of the study population.
Fig. 4. Prevalence of hypertension and treatment profile of study partici-
pants.
Fig. 5. Distribution of number of antihypertensive drug classes used per 
individual.
Fig. 6. Pharmacological classes used in the study population.
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patients, and recommend that ARBs be used instead, as second-line 
agents in combination with the first-line CCBs. Thiazide diuretics 
are recommended after the combination of CCBs and ARBs has 
failed, or in some instances as first-line therapy when CCBs are 
contraindicated.18 Prescribing practices in the mining population 
must be re-evaluated in this context.
Approximately two-thirds of hypertensive patients cannot be 
controlled on one drug alone, and will require two or more drugs 
from different classes.19,20 In the ALLHAT study, 60% of those whose 
BP was controlled to target (<140/90 mmHg) received two or more 
antihypertensive agents. Only 30% were controlled on one drug.19 In 
our study in predominantly black patients, 18.4% were controlled on 
monotherapy, which was low in comparison to the ALLHAT study. 
Furthermore, in our study 45.7% were controlled on two drugs while 
35.9% of those controlled required three or more drugs, reflecting 
the difficulty in effectively treating hypertension in black patients. 
Of note is that miners are not allowed underground if their BP is not 
adequately controlled.
We did not examine non-pharmacological means of BP control. 
Lifestyle interventions such as restricting salt intake, reducing body 
weight and limiting alcohol, tobacco and caffeine use decrease BP 
and improve antihypertensive drug efficacy. Other important lifestyle 
measures include a low-fat, high-fibre diet and regular moderate-
intensity exercise.18,21 Although the miners had access to dieticians, it 
is not known whether dietary advice was followed or whether other 
lifestyle modifications were implemented. This is an important area 
for additional research.
The study also failed to elucidate other potential causes of 
uncontrolled BP, e.g. poor adherence to treatment because of long 
duration of therapy, complicated regimens, side-effects of drugs, 
misunderstanding instructions and the asymptomatic nature of 
hypertension, among others.18,21 The South African guidelines for the 
treatment of hypertension emphasise this point succinctly.21 Further 
studies are also required to assess interventions to support adherence.
Despite these limitations, the study presents information on the 
prevalence, treatment and control of hypertension in Harmony 
North Operations, which is unusual in South Africa as it has excellent 
screening and medical facilities.
Conclusion
Hypertension is a ‘silent killer’ affecting millions of people worldwide 
despite advances in its diagnosis and treatment. This study confirms 
the high prevalence of hypertension in a largely black mining 
population and provides first-time analysis of its prevalence, 
treatment and control in this setting. These findings highlight 
the urgent need to implement cost-effective strategies, targeting 
individuals and health care providers to prevent hypertension and 
improve treatment and BP control in this population.
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Agapanthus now;
      The geese screeching endlessly –
      Moving to closure.
   Haiku: Peter Folb
